Drug modulation by nuclear condensates - PubMed (original) (raw)

Comment

Drug modulation by nuclear condensates

Aaron D Viny et al. Science. 2020.

No abstract available

PubMed Disclaimer

Figures

None

Pharmacophore-specific condensates

Cisplatin and tamoxifen aggregate in transcriptional condensates, affecting their pharmacokinetics. Cisplatin freely diffuses through HP1-labeled heterochromatin and accumulates in MED1 condensates. The BRD4 inhibitor JQ.1 abrogates MED1 condensates and attenuates drug-induced platination. Tamoxifen displaces ERα from target genes, but mutations that induce tamoxifen resistance (mERα) shift affinity as tamoxifen is evicted from transcriptional condensates. BRD4, bromodomain-containing protein 4; ERα, estrogen receptor α; HP1, heterochromatin protein 1; MED1, mediator of RNA polymerase II transcription subunit 1.

Comment on

Similar articles

Cited by

References

    1. Brangwynne CP, Mitchison TJ, Hyman AA, Proc. Natl. Acad. Sci. U.S.A 108, 4334 (2011). - PMC - PubMed
    1. Feric M et al. Cell 165, 1686 (2016). - PMC - PubMed
    1. Klein IA et al. 368, 1386 (2020). - PMC - PubMed
    1. Boija A et al. Cell 175, 1842 (2018). - PMC - PubMed
    1. Sabari BR et al. Science 361, eaar3958 (2018). - PubMed

Publication types

MeSH terms

LinkOut - more resources